BIOCON LIMITED

Company Overview

The Biocon Limited is an organization that pioneers in research driven therapies, which combats the diseases.  The innovation is an attribute which drives this company

2)   Company overview

The research and development wing is active all the time to invent new drugs to fight life taking cancer, sugar and other auto immune diseases.  This is regarded as the fourth largest insulin Organization and has contributed handsomely in the development of the insulin. The recombinant human insulin is developed by the company. It has meaningful contributions in fighting cancer as well. They were the first to produce antibody for the head and the neck cancer. HER2 is the treatment launched by the firm to fight breast cancer. This has facilitated many women to avail of the treatment in many countries. CANMAb is the most successful oncology product developed by them. The organization is on its course to set up Asias’ largest Research and Development hub in Malaysia. The company proudly claims and rightly so that the constant research has helped many people receive the best medicines at very competitive price. The backward, poverty stricken class been introduced to best healthcare by the dint of the innovated drugs. The backbone of the company lies in the great talent it holds. More than 7500 employees work in the Biocon park in Bangalore. A noble dimension of the organization is reflected in their CSR activities. It primarily focuses on the healthcare, the education and the Civic Infrastructures.

2)    Products and Services

There has been a huge transition and up gradation in the products and services with the passage in time.The influence of technology has helped the company stamp their authority in the fields of small molecules, enzymes, recombinant proteins and antibodies. It has launched a number of medicines that have become the automatic choice for the doctors. INSUGEN, BASALOG, INSUPen are some of the medicines launched by them that has attained extreme acceptability among the patients.  The acquisitions have also helped them in honing the expertise in developing the pharmaceutical products .It also provides the knowledge of bio-manufacturing to various pharmaceutical companies within and outside the country. The research engine is hinged on two specially developed units, the Syngene and the Clinigene. While the former looks into the custom research, the latter takes care of the clinical research. Development and support for both the large molecule and small molecule are supported.

3)    Awards and achievements

The company has achieved a lot of recognition since its inception. It has bagged many awards such as the “Export performance award”, “ Bio-Business award for bio entrepreneurship”, “ Best IT user award in the Pharmaceutical sector” by Nasscom,  “Best patent of the year, IDMA” , “Bio services company of the year”, “Sir J C Bose memorial award”. This list is only a tip of the iceberg. There is lot more to this tally.

4)    Career

The fact that Biocon Limited featured in the “Top twenty Global Employers” in the year 2012,  and “Top six Global employers in Pharmaceuticals” alone sets up the reason why the bright students should choose this as a career platform. The working environment is fantastic to say the least. The opportunity to grow with the company lures the intellectuals to join this company.